A detailed history of Advisor Group Holdings, Inc. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,636 shares of WVE stock, worth $23,345. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,636
Previous 1,193 37.13%
Holding current value
$23,345
Previous $5,000 160.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.12 - $9.01 $2,268 - $3,991
443 Added 37.13%
1,636 $13,000
Q2 2024

Aug 13, 2024

BUY
$4.38 - $6.48 $5,225 - $7,730
1,193 New
1,193 $5,000
Q2 2022

Aug 10, 2022

SELL
$1.23 - $3.25 $615 - $1,625
-500 Closed
0 $0
Q1 2020

May 18, 2020

BUY
$6.94 - $14.22 $3,470 - $7,110
500 New
500 $5,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.